Prajapati V, Singh A, Kumar A, Singh H, Pathak P, Grishina M
RSC Med Chem. 2025; .
PMID: 40052089
PMC: 11880839.
DOI: 10.1039/d4md00923a.
Wang W, Li Y, Ko S, Feng N, Zhang M, Liu J
bioRxiv. 2024; .
PMID: 38798496
PMC: 11118288.
DOI: 10.1101/2024.05.11.593690.
Cherri S, Melocchi L, Gandolfi L, Rossi G, Zaniboni A
Life (Basel). 2023; 13(2).
PMID: 36836752
PMC: 9967356.
DOI: 10.3390/life13020395.
Baleeiro R, Chard Dunmall L, Liu P, Lu S, Lone Y, Lemoine N
Front Immunol. 2022; 13:902709.
PMID: 35720289
PMC: 9204602.
DOI: 10.3389/fimmu.2022.902709.
Yao Y, Wang X, Zhao X, Li S, Zhou Y, Xu Y
Zhongguo Dang Dai Er Ke Za Zhi. 2022; 24(3):309-313.
PMID: 35351263
PMC: 8974658.
DOI: 10.7499/j.issn.1008-8830.2109141.
Combination of artesunate and WNT974 induces KRAS protein degradation by upregulating E3 ligase ANACP2 and β-TrCP in the ubiquitin-proteasome pathway.
Gong R, Chen M, Huang C, Wong H, Kwan H, Bian Z
Cell Commun Signal. 2022; 20(1):34.
PMID: 35305671
PMC: 8934478.
DOI: 10.1186/s12964-022-00834-2.
A proximity proteomics screen in three-dimensional spheroid cultures identifies novel regulators of lumen formation.
Wang L, Proulx M, Kim A, Lelarge V, McCaffrey L
Sci Rep. 2021; 11(1):22807.
PMID: 34815476
PMC: 8610992.
DOI: 10.1038/s41598-021-02178-2.
RAS Function in cancer cells: translating membrane biology and biochemistry into new therapeutics.
Kattan W, Hancock J
Biochem J. 2020; 477(15):2893-2919.
PMID: 32797215
PMC: 7891675.
DOI: 10.1042/BCJ20190839.
A conserved, N-terminal tyrosine signal directs Ras for inhibition by Rabex-5.
Washington C, Chernet R, Gokhale R, Martino-Cortez Y, Liu H, Rosenberg A
PLoS Genet. 2020; 16(6):e1008715.
PMID: 32559233
PMC: 7329146.
DOI: 10.1371/journal.pgen.1008715.
Aristolochic Acid-Induced Genotoxicity and Toxicogenomic Changes in Rodents.
Li X, Guo X, Wang H, Chen T, Mei N
World J Tradit Chin Med. 2020; 6(1):12-25.
PMID: 32258091
PMC: 7110418.
DOI: 10.4103/wjtcm.wjtcm_33_19.
Oncogenic K-Ras4B Dimerization Enhances Downstream Mitogen-activated Protein Kinase Signaling.
Muratcioglu S, Aydin C, Odabasi E, Ozdemir E, Firat-Karalar E, Jang H
J Mol Biol. 2020; 432(4):1199-1215.
PMID: 31931009
PMC: 8533050.
DOI: 10.1016/j.jmb.2020.01.002.
Identification of novel genetic variants predisposing to familial oral squamous cell carcinomas.
Huang Y, Zhao J, Mao G, Lee G, Zhang J, Bi L
Cell Discov. 2019; 5:57.
PMID: 31798960
PMC: 6877579.
DOI: 10.1038/s41421-019-0126-6.
An Application of pET SUMO Protein Expression System in Escherichia coli: Cloning, Expression, Purification, and Characterisation of Native Kras4B Oncoprotein.
Tan M, Teh Y, Ho K, Stanslas J
Protein J. 2019; 39(1):54-61.
PMID: 31620959
DOI: 10.1007/s10930-019-09872-1.
Personalized treatment options for thyroid cancer: current perspectives.
Khatami F, Larijani B, Nikfar S, Hasanzad M, Fendereski K, Tavangar S
Pharmgenomics Pers Med. 2019; 12:235-245.
PMID: 31571972
PMC: 6750856.
DOI: 10.2147/PGPM.S181520.
Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma.
Best S, Ding S, Kersbergen A, Dong X, Song J, Xie Y
Nat Commun. 2019; 10(1):4190.
PMID: 31519898
PMC: 6744438.
DOI: 10.1038/s41467-019-12164-y.
NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease.
Aydin E, Hallner A, Grauers Wiktorin H, Staffas A, Hellstrand K, Martner A
Oncogene. 2018; 38(9):1534-1543.
PMID: 30323311
PMC: 6372471.
DOI: 10.1038/s41388-018-0528-1.
Mutation analysis of the EGFR pathway genes, and , in salivary gland adenoid cystic carcinoma.
Saida K, Murase T, Ito M, Fujii K, Takino H, Masaki A
Oncotarget. 2018; 9(24):17043-17055.
PMID: 29682203
PMC: 5908304.
DOI: 10.18632/oncotarget.24818.
Raf-1 Cysteine-Rich Domain Increases the Affinity of K-Ras/Raf at the Membrane, Promoting MAPK Signaling.
Li S, Jang H, Zhang J, Nussinov R
Structure. 2018; 26(3):513-525.e2.
PMID: 29429878
PMC: 8183739.
DOI: 10.1016/j.str.2018.01.011.
The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma.
Wan X, Liu R, Li Z
Biomed Res Int. 2018; 2017:5356737.
PMID: 29349077
PMC: 5733767.
DOI: 10.1155/2017/5356737.
Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence hybridization (FISH) to select the optimal patients for matched therapy?.
Chae Y, Arya A, Chiec L, Shah H, Rosenberg A, Patel S
Oncotarget. 2017; 8(59):100863-100898.
PMID: 29246028
PMC: 5725070.
DOI: 10.18632/oncotarget.19809.